What BennuBio does

BennuBio is a privately held life-sciences instrumentation company headquartered in Albuquerque, New Mexico, founded in 2018 with a headcount of 1–10 employees. The company is developing analytical instruments that extend the flow cytometry paradigm to samples of arbitrary particle size and volume — a technical positioning that, if validated, would broaden cytometry beyond its traditional cellular-scale use cases into larger-particle, higher-volume, or non-standard-sample workflows.

The company has assembled a science-led operating team comprising a Founder & Chief Science Officer (James Freyer), a Chief Executive Officer (Steven Graves), a Chief Financial Officer (Steve McKernan), and a Chief Technology Officer (Travis Woods). Capital formation has been the dominant strategic activity to date: a $1.5M seed in September 2018, a $5.0M Series A in April 2020 led by Cowin Venture with co-investment from Cottonwood Technology Fund, Sun Mountain Capital, Tramway Venture Partners, and New Mexico Vintage Fund, followed by small follow-on tranches from New Mexico Angels in 2022 ($45K) and 2023 ($10K), and participation in the BioTools Innovator program in June 2023. No commercial product launch, customer logo, revenue figure, or go-to-market motion is disclosed in the available data, indicating the company remains in an early development or pre-commercial stage.

Note on the input: a substantial block of the aggregated material describes an unrelated online gambling platform (Pinco Casino / Carlitta N.V.) under the BennuBio record, which appears to be a data-attribution error. The company description above is grounded in the firmographic, funding, and leadership data that consistently describe a flow-cytometry instrumentation business.

Name

BennuBio

Legal name

Carlitta N.V.

Website

https://bennubio.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

1–10 employees

Short description

BennuBio is a privately held Albuquerque-based life-sciences instrumentation company (founded 2018, 1–10 employees) developing flow cytometry-based analyzers capable of handling samples of arbitrary particle size and volume.

Ownership category

akta.pro rank

Product category

Flow Cytometry Instrumentation

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

SIC

Laboratory Analytical Instruments (3826)

akta.pro primary industry

Microscopy, Imaging & Flow Cytometry Instruments (HLAGAIAE)

akta.pro secondary industries

Flow Cytometry & Cellular Analysis Diagnostics (HLAHAAAF), Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics) (HLAHAAAN)

Keywords

• Flow cytometry instruments
• Cell analysis systems
• Life sciences instrumentation
• Particle size analysis
• Biotech research tools

Headquarters

HQ city

Albuquerque

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales

Revenue model

1. Online Casino Gaming: Platform charges a house edge on casino games including slots, table games, and live dealer games. Revenue generated from player losses on games.
2. Sports Betting: Commission earned on sports betting wagers across live and pre-match markets for football, tennis, esports, and cyber sports.
3. Bonus Wagering Requirements: Revenue generated when players fail to meet wagering requirements on bonuses (x50 multiplier on welcome bonuses, x50 on freespin wagers, x3 on cashback).

Pricing tiers

Distribution channels3 records

Marketing channels4 records

Core offering

BennuBio develops flow cytometry-based instruments that analyze biological samples regardless of particle size or sample volume. The technology applies the standard flow cytometry paradigm to a broader range of sample types, enabling research and clinical applications beyond the constraints of conventional flow cytometry systems.

Product overview

Pinco Casino is an online gambling platform licensed by Curaçao eGaming. The platform offers a unified product combining casino gaming (slots, live dealers, crash games) with sports betting (pre-match and live betting on football, tennis, esports). It includes a mobile Android application and supports local Azerbaijani payment methods (m10, eManat) alongside cryptocurrency. The platform features a loyalty program with Pincoins and various bonuses including welcome packages, freespins, and weekly cashback.

Differentiator

Problem solved

Functional benefit

Products and services

• Flow Cytometry Instrument Platform

Quantifiable outcome

• Minimum deposit as low as 5 AZN
• +2 more outcomes

Segments3 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Nine partnerships are on record, tiered core.

• Curaçao eGamingcoreOthersLicensing authority providing international gambling license 8048/JAZ for legal operation. Regulates and monitors gaming activities ensuring compliance with international standards.
• Evolution GamingcoreTechnology or IntegrationLive dealer game provider powering real-time casino experiences including roulette, blackjack, and baccarat tables.
• Pragmatic PlaycoreTechnology or IntegrationSlot game provider offering premium titles like Big Bass Bonanza. One of the leading content suppliers for the platform.
• Nolimit CitycoreTechnology or IntegrationSlot game developer providing high-volatility titles like Mental with unique xWays and xNudge mechanics.
• Relax GamingcoreTechnology or IntegrationSlot game developer providing Money Train 3 with persistent payer and bonus round features.
• SpribecoreTechnology or IntegrationCrash game provider powering Aviator with 97% RTP and controlled risk mechanics.
• Carlitta N.V.coreOthersOperating company managing the Pinco Casino platform under Curaçao eGaming license.
• m10 Payment SystemcoreChannel Partner/ Reseller/ DistributorLocal Azerbaijani payment system integrated for deposits and withdrawals with processing times of 15 minutes to 2 hours.
• eManat Payment TerminalscoreChannel Partner/ Reseller/ DistributorPhysical payment terminal network in Azerbaijan enabling cash deposits to user accounts instantly.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Beckman Coulter Life Sciences: Part of Danaher's Life Sciences segment and one of the largest manufacturers of flow cytometry instruments and reagents. Directly comparable as an established flow cytometry hardware competitor with deep clinical and research installed base.
• BD Biosciences: BD's cell analysis franchise (including the FACSDuet, FACSChorus, and BD FACSDiscover systems) is a market-leading flow cytometry platform serving research and clinical diagnostics. Comparable as the dominant incumbent in conventional flow cytometry.
• Thermo Fisher Scientific (Life Sciences / Cell Analysis): Markets the Attune NxT flow cytometer and a broad portfolio of flow cytometry antibodies, kits, and instruments. Comparable as a large incumbent covering both flow cytometry hardware and consumables.
• Bio-Rad Laboratories: Life-science research tools provider with the ZE5 cell analyzer and a broad flow cytometry / droplet digital PCR portfolio. Comparable as an incumbent in cell analysis instrumentation serving research and biopharma workflows.
• Sony Biotechnology: Provider of the SH800 and MA900 cell sorters and the SA3800 spectral analyzer — competes in flow cytometry cell sorting with proprietary microfluidics/optics. Comparable as a specialty instrumentation competitor that has commercialized novel flow cytometry architectures.

Direct peers

• Cytek Biosciences: Developer of the Aurora and Northern Lights spectral flow cytometers, a newer-generation flow cytometry platform that has gained significant share in immunology and immuno-oncology research. Closest direct comparable as a venture-backed flow cytometry instrument company that displaced incumbents with a differentiated optical architecture.
• Stratedigm: Specialty manufacturer of high-performance flow cytometry instruments (S1000, SE520) targeting research and biopharma customers. Comparable as a smaller, specialized flow cytometry hardware peer focused on flexibility and configurability.
• Apogee Flow Systems: UK-based specialist in flow cytometry instruments capable of measuring small particles and bacteria — directly aligned with BennuBio's "regardless of particle size" positioning. Comparable as a niche flow cytometry peer targeting applications that conventional cytometers cannot address.

Emerging players

• Cytovale: Diagnostics company using cell mechanical properties and rapid cytometry-based technology (IntelliSep) for sepsis triage. Comparable as a flow cytometry-adjacent tools company applying the paradigm to clinical diagnostic use cases — BennuBio's "any particle size or sample volume" positioning points toward similar adjacent applications.
• DeNovix: Specialty lab instrumentation company (cell counters, spectrophotometers, fluorometers) that has scaled from a small startup into a multi-product life-science tools business. Comparable as a small-cap life-science instrumentation peer that has successfully scaled specialized bench-top instruments.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds5 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BennuBio